Ceftazidime Inj 1 g Brand Change
As advised via Pharmac Tender announcement 31 May 2017, there is to be a change in the listing and future sole supply.
New listing HML from 1 January 2018
Ceftazidime Hospira Inj 1 g vial Pharmacode 2245574 Schedule price $2.20
Fortum Inj 1 g vial Pharmacode 332941 Schedule price $1.55
Delisting HML 1 March 2018. (stocks are depleted)
Alternative temporary listing
Ceftazidime Mylan Inj 1 g 5 vial Pharmacode 2452294 Schedule price $23.00
Once again we need your support to ensure stock in the supply chain moves through to effectively ensure no losses are incurred.
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.